📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial. (2024)

First Author: Morrow A

Attributed to: MICA: A Developmental Trial of Personalised Medicine for Repurposing Zibotentan, a Selective Endothelin A Receptor Blocker, in Microvascular Angina. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.124.069901

PubMed Identifier: 39217504

Publication URI: http://europepmc.org/abstract/MED/39217504

Type: Journal Article/Review

Volume: 150

Parent Publication: Circulation

Issue: 21

ISSN: 0009-7322